
Nymox Pharmaceutical Corp (QB) (NYMXF)
USOTC
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 283k | 224k | 299k | 116k | 5k | 0 | 0 | 0 |
Operating Income | -12.87M | -13.24M | -10.64M | -13.33M | -11.72M | -12.5M | -6.65M | -8.79M |
Pre Tax Income | -13.11M | -13.43M | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M | -8.84M |
Net Income | -13.11M | -13.43M | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M | -8.84M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
EBIT | -12.87M | -13.24M | -10.64M | -13.33M | -11.72M | -12.5M | -6.54M | -8.79M |
EBITDA | -12.87M | -13.23M | -10.64M | -13.33M | -11.71M | -12.49M | -6.64M | -8.78M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.